** Shares of Pacific Edge PEB.NZ down 5.5% at NZ$0.171, set for their weakest session since mid-September, if current trend holds

** The cancer diagnostics company posts first-half 2026 net loss after tax of NZ$19.1 million ($10.72 million), versus loss of NZ$14.5 million from a year before

** Adds that first-half total operating revenue at NZ$5.9 million versus NZ$11 million last year

** About 1.9 million shares change hands, 4.1x the 30-day average

** YTD, stock up 36.8%, including the day's move

($1 = 1.7809 New Zealand dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Nikita.Jino@thomsonreuters.com;))